Results 61 to 70 of about 7,176 (216)
Background Fibrocystic changes are a common benign condition in women aged 20–50. The medical intervention aims to stop fibrocystic disease progress and relieve the breast’s pain and tenderness. In the long-term, reversing the fibrocystic changes is also
Gholamali Godazandeh +4 more
doaj +1 more source
Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis [PDF]
Background. We report the safety findings from a 3-year phase 3 study (NCT00205777) of bazedoxifene, a novel selective estrogen receptor modulator under development for the prevention and treatment of postmenopausal osteoporosis. Methods.
Claus Christiansen +9 more
core +1 more source
This cross‐sectional study included 201 women, comprising 106 patients with non‐cyclical mastalgia (NCM) and 95 healthy controls, to analyze the correlation between NCM and central sensitization syndromes (CSS). NCM patients showed higher central sensitization scores and a greater burden of pain, anxiety, depression, and sleep disturbances compared to ...
Pelin Basım +4 more
wiley +1 more source
Relationship of Fibrocystic Disease to Carcinoma of the Breast
This investigation evaluated the relationship of proliferative chang es to the development of human breast cancer. Of 838 consecutive cases of breast lesions operated on at Flower and Fifth Avenue Hospitals data were adequate in 719: 74 fibroadenomas and 645 which were included in the study.
C M, KARPAS +3 more
openaire +3 more sources
Follow-up of women with breast cancer: comparison between MRI and FDG PET [PDF]
.: The aim of this study was to compare MRI of the breast with 18F-fluoro-deoxy-glucose (FDG) positron emission tomography (PET) in patients with suspected local or regional breast cancer recurrence or suspected contralateral breast cancer.
Fehr, Mathias +7 more
core
An Approach for Differential Diagnosis of Breast Tumors by ctDNA Methylation Sequencing
ABSTRACT Background Breast ultrasonography and mammography remain predominant in breast tumor evaluations, yet they often result in false positives, particularly for tumors classified as BI‐RADS 4a or those no more than 10 mm, which are not ideal for core needle biopsy (CNB).
Xianyu Zhang +26 more
wiley +1 more source
Hepatocyte growth factor profile with breast cancer
Background: The multifunctional hepatocyte growth factor (HGF) is the ligand of c-Met receptor; it plays important role in mammary differentiation. HGF-Met signaling is a critical downstream function of c-Src-Stat3 pathway in mammalian tumorigenesis. Aim:
Hoda A EL-Attar, Manal I Sheta
doaj +1 more source
Abstract Models based on magnetic resonance imaging (MRI) and contrast‐enhanced mammography (CEM) radiomics for noninvasive prediction of nonsentinel lymph node (NSLN) metastasis were developed in this study. A total of 270 patients who had undergone axillary lymph node dissection from January 2018 to October 2022 and were diagnosed with 1–2 positive ...
Wei Jiang +7 more
wiley +1 more source
Vacuum-assisted breast biopsy: A comparison of 11-gauge and 8-gauge needles in benign breast disease [PDF]
Background Minimal invasive breast biopsy is standard care for the diagnosis of suspicious breast lesions. There are different vacuum biopsy (VB) systems in use.
Markus Hahn +25 more
core +2 more sources
Objectives Our study aims to compare the diagnostic performance of superb microvascular imaging (SMI) and dynamic contrast‐enhanced magnetic resonance imaging (MRI) in differentiating benign from malignant breast masses, using histopathological findings as the reference standard.
Ahmet Yasin Yitik +2 more
wiley +1 more source

